Immuron in Travelan Clinical Trial Agreement with US-based Pharmaron

 

• Clinical Trial Master Service Agreement with US-based Pharmaron Executed

• Investigational New Drug (IND) application to be submitted to the U.S. Food and Drug administration (FDA)

• Plans in place to initiate a Controlled Human Infection Model (CHIM) clinical trial in 60 healthy volunteers in the USA

• Clinical Trial to examine a dosing regimen for Travelan more suited for use by the US military

• Infectious diarrhea is the most common illness reported by travelers

https://finance.yahoo.com/news/immuron-executes-travelan-clinical-trial-100000838.html